Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Deferred Taxes: 2022-2024

Historic Deferred Taxes for GeneDx Holdings (WGS) over the last 3 years, with Dec 2024 value amounting to -$343,000.

  • GeneDx Holdings' Deferred Taxes rose 623.40% to $246,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $424,000, marking a year-over-year increase of 158.08%. This contributed to the annual value of -$343,000 for FY2024, which is 62.96% up from last year.
  • GeneDx Holdings' Deferred Taxes amounted to -$343,000 in FY2024, which was up 62.96% from -$926,000 recorded in FY2023.
  • In the past 5 years, GeneDx Holdings' Deferred Taxes registered a high of -$343,000 during FY2024, and its lowest value of -$49.1 million during FY2022.
  • Moreover, its 3-year median value for Deferred Taxes was -$926,000 (2023), whereas its average is -$16.8 million.
  • Data for GeneDx Holdings' Deferred Taxes shows a peak YoY soared of 98.11% (in 2023) over the last 5 years.
  • GeneDx Holdings' Deferred Taxes (Yearly) stood at -$49.1 million in 2022, then spiked by 98.11% to -$926,000 in 2023, then skyrocketed by 62.96% to -$343,000 in 2024.